Search for: "Jason Rantanen"
Results 201 - 220
of 376
Sorted by Relevance
|
Sort by Date
18 Oct 2019, 4:00 am
By Jason Rantanen I’m thrilled to announce the publication of the articles from the Iowa Law Review’s symposium, Administering Patent Law. [read post]
31 Aug 2011, 1:27 pm
By Jason Rantanen Classen Immunotherapies, Inc. v. [read post]
12 Mar 2013, 7:23 am
DiCola (see my last most-downloaded post for links)The Federal Circuit's New Obviousness Jurisprudence: An Empirical Study, by Jason Rantanen (Jason posted about this on Patently-O)Orphan Works and the Search for Rightsholders: Who Participates in a 'Diligent Search' under Present and Proposed Regimes? [read post]
16 Aug 2010, 12:13 pm
., August 5, 2010)Panel: Linn, Moore (author), FriedmanBy Jason RantanenAdams holds patent number 5,372,252, which covers an extended release formulation containing guaifenesin (an expectorant used to thin, loosen, and help expel mucus that causes congestion). [read post]
13 Jan 2020, 9:50 am
By Jason Rantanen While most commentators are focusing on year-in-reviews, I thought it would be fun to do a decade-in-review using data from the Compendium of Federal Circuit Decisions, the publicly-accessible dataset that we’ve developed at Iowa Law containing information about all decisions by the Federal Circuit since 2008. [read post]
31 May 2011, 8:01 am
By Jason Rantanen Global-Tech Appliances, inc. v. [read post]
8 Feb 2012, 7:06 am
According to Jason Rantanen and Lee Petherbridge, there is a problem with the Leahy-Smith America Invents Act (AIA). [read post]
26 May 2014, 12:00 pm
By Jason Rantanen Earlier this month, I posed a question relating to the patent eligibility of the following claim: A method for guiding the selection of a therapeutic treatment regimen for a patient with a known disease or medical condition, said method comprising: (a) providing patient information to a computing device comprising: a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition; a second… [read post]
8 Feb 2012, 7:06 am
According to Jason Rantanen and Lee Petherbridge, there is a problem with the Leahy-Smith America Invents Act (AIA). [read post]
12 Jul 2010, 9:03 am
Universal Security Instruments by Jason Rantanen New Contributing Author: Jason Rantanen My friend Jason Rantanen has agreed to become a contributing author on Patently-O for the next few months. [read post]
16 Sep 2012, 11:58 am
, by Jason Rantanen & Lee Petherbridge (summarized by Rantanen on Patently-O)Hollywood Deals: Soft Contracts for Hard Markets, by Jonathan BarnettFeaturing People in Ads, by Eric Goldman & Rebecca TushnetSolving the Patent Settlement Puzzle, by Einer Elhauge & Alex KruegerWhile all of these articles look interesting, as I've noted before, I think there is only a weak correlation between SSRN downloads and quality of scholarship; e.g., right now I am… [read post]
27 Jun 2014, 12:54 pm
By Jason Rantanen Teva recently filed its merits brief in Teva v. [read post]
26 Jan 2012, 12:52 pm
By Jason Rantanen Yesterday, the United States Patent and Trademark Office announced the proposed rules for supplemental examinations and proposed revisions to ex parte reexamination fees. [read post]
12 Feb 2016, 12:08 pm
By Jason Rantanen Lexmark International, Inc. v. [read post]
24 Apr 2012, 12:52 pm
By Jason Rantanen Advanced Fiber Technologies (AFT) Trust v. [read post]
10 Jun 2015, 8:11 am
By Jason Rantanen Virginia Innovation Sciences, Inc. v. [read post]
17 Oct 2014, 10:19 am
By Jason Rantanen I’m a moderately-dedicated baseball fan*, so I’ve been listening** to quite a few baseball games over the past few weeks. [read post]
13 Aug 2015, 11:47 am
By Jason Rantanen Akamai Technologies, Inc. v. [read post]
6 May 2015, 11:10 am
By Jason Rantanen Biosig Instruments, Inc. v. [read post]
3 Jun 2014, 11:11 am
By Jason Rantanen Yesterday, following the Supreme Court’s unanimous reversal of the Federal Circuit in Nautilus and Limelight, Vera Ranieri of the Electronic Frontier Foundation observed that: These rulings mean that the Federal Circuit has been unanimously overruled in every single patent case heard by the Supreme Court this term. [read post]
